Amedeo Smart

Free Medical Literature Service

 

Amedeo

Cytomegalovirus Infection
  Free Subscription

Articles published in
Clin Infect Dis
    February 2024
  1. HAMMOND SP, Little JS
    How much does cytomegalovirus viremia matter after chimeric antigen receptor T-cell therapy?
    Clin Infect Dis. 2024 Feb 2:ciae053. doi: 10.1093.
    >> Share

  2. KAMPOURI E, Boeckh MJ, Hill JA
    Understanding the clinical significance of cytomegalovirus viremia after chimeric antigen receptor T-cell therapy: Should we be treating a value?
    Clin Infect Dis. 2024 Feb 2:ciae030. doi: 10.1093.
    >> Share

    January 2024
  3. YATES TA, Halliday N
    Re: Association of CMV DNAemia with Long-Term Mortality in a Randomized Trial of Preemptive Therapy (PET) and Antiviral Prophylaxis (AP) for Prevention of CMV Disease in High-Risk Donor Seropositive, Recipient Seronegative (D+R-) Liver Transplant Reci
    Clin Infect Dis. 2024 Jan 9:ciae004. doi: 10.1093.
    >> Share

  4. KUMAR L, Dasgupta S, Murray-Krezan C, Singh N, et al
    Response to Yates and Halliday regarding CMV DNAemia and time-to-mortality in a Randomized Trial of PET vs AP in CMV D+R-Liver Transplant Recipients.
    Clin Infect Dis. 2024 Jan 8:ciae005. doi: 10.1093.
    >> Share

    November 2023
  5. PAPANICOLAOU GA, Avery RK, Cordonnier C, Duarte RF, et al
    Treatment for First Cytomegalovirus Infection Post-Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir with Valganciclovir.
    Clin Infect Dis. 2023 Nov 30:ciad709. doi: 10.1093.
    >> Share

  6. KAMPOURI E, Ibrahimi SS, Xie H, Wong ER, et al
    CMV Reactivation and CMV-Specific Cell-Mediated Immunity after Chimeric Antigen Receptor T-Cell Therapy.
    Clin Infect Dis. 2023 Nov 17:ciad708. doi: 10.1093.
    >> Share

    October 2023
  7. KUMAR L, Dasgupta S, Murray-Krezan C, Singh N, et al
    Association of CMV DNAemia with Long-Term Mortality in a Randomized Trial of Preemptive Therapy (PET) and Antiviral Prophylaxis (AP) for Prevention of CMV Disease in High-Risk Donor Seropositive, Recipient Seronegative (D+R-) Liver Transplant Recipien
    Clin Infect Dis. 2023 Oct 20:ciad643. doi: 10.1093.
    >> Share

    September 2023
  8. MANUEL O, Laager M, Hirzel C, Neofytos D, et al
    Immune monitoring-guided vs fixed duration of antiviral prophylaxis against cytomegalovirus in solid-organ transplant recipients. A Multicenter, Randomized Clinical Trial.
    Clin Infect Dis. 2023 Sep 22:ciad575. doi: 10.1093.
    >> Share

  9. PORTILLO V, Masouridi-Levrat S, Royston L, Yerly S, et al
    Revisiting cytomegalovirus serology in allogeneic hematopoietic cell transplant recipients.
    Clin Infect Dis. 2023 Sep 15:ciad550. doi: 10.1093.
    >> Share

    May 2023
  10. AMIR J, Chodick G, Pardo J
    Revised protocol for secondary prevention of congenital cytomegalovirus infection with valaciclovir following infection in early pregnancy.
    Clin Infect Dis. 2023 May 9:ciad230. doi: 10.1093.
    >> Share

    March 2023
  11. PLOTKIN SA
    Can We Prevent Congenital Infection By Cytomegalovirus?
    Clin Infect Dis. 2023 Mar 28:ciad179. doi: 10.1093.
    >> Share

    January 2023
  12. LEVI LI, Molina JM
    Cytomegalovirus (CMV) viremia in people with Human Immunodeficiency Virus (HIV): should we treat the CMV? Or the HIV? or Both?
    Clin Infect Dis. 2023 Jan 10:ciad011. doi: 10.1093.
    >> Share


  13. Correction to: Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial.
    Clin Infect Dis. 2023 Jan 6:ciac970. doi: 10.1093.
    >> Share

    December 2022
  14. FANG MZ, Jackson SS, Pfeiffer RM, Kim EY, et al
    No Association of IFNL4 Genotype With Opportunistic Infections and Cancers Among Men With Human Immunodeficiency Virus 1 Infection.
    Clin Infect Dis. 2022 Dec 27:ciac447. doi: 10.1093.
    >> Share

    November 2022
  15. FANG M, Lin X, Wang C, Yang X, et al
    High cytomegalovirus viral load is associated with 182-day all-cause mortality in hospitalized people with human immunodeficiency virus (PWH).
    Clin Infect Dis. 2022 Nov 14. pii: 6827090. doi: 10.1093.
    >> Share

    August 2022
  16. SCHNITTMAN SR, Lu MT, Mayrhofer T, Burdo TH, et al
    Cytomegalovirus IgG Titer and Coronary Artery Disease in People with HIV.
    Clin Infect Dis. 2022 Aug 17. pii: 6668874. doi: 10.1093.
    >> Share

  17. CHEVALIER K, Schmidt J, Coppo P, Galicier L, et al
    Hemophagocytic lymphohistiocytosis associated with cytomegalovirus infection: five cases and a systematic review of the literature.
    Clin Infect Dis. 2022 Aug 17. pii: 6668866. doi: 10.1093.
    >> Share

    June 2022
  18. LILLERI D, Tassis B, Pugni L, Ronchi A, et al
    Prevalence, outcome, and prevention of congenital cytomegalovirus infection in neonates born to women with preconception immunity (CHILd study).
    Clin Infect Dis. 2022 Jun 19. pii: 6611487. doi: 10.1093.
    >> Share

    April 2022
  19. ALYSSA FITZPATRICK A, Cooper C, Vasilunas N, Ritchie B, et al
    Describing the impact of maternal hyperimmune globulin and valaciclovir on the outcomes of CMV infection in pregnancy: a systematic review.
    Clin Infect Dis. 2022 Apr 19. pii: 6570695. doi: 10.1093.
    >> Share

    January 2022
  20. SU Y, Stern A, Karantoni E, Nawar T, et al
    Impact of letermovir primary Cytomegalovirus (CMV) prophylaxis on 1-year mortality after allogeneic hematopoietic cell transplantation (HCT): a retrospective cohort study.
    Clin Infect Dis. 2022 Jan 3. pii: 6494526. doi: 10.1093/cid/ciab1064.
    >> Share

    December 2021
  21. AVERY RK, Alain S, Alexander BD, Blumberg EA, et al
    Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results from a Phase 3 Randomized Clinical Trial.
    Clin Infect Dis. 2021 Dec 2. pii: 6448443. doi: 10.1093.
    >> Share

    November 2021
  22. LANZIERI TM, Kruszon-Moran D, Dollard SM
    Cytomegalovirus seroprevalence among U.S. children 1 to 5 years of age: The National Health and Nutrition Examination Surveys (NHANES), 2017 - March 2020 Pre-pandemic dataset.
    Clin Infect Dis. 2021 Nov 8. pii: 6423497. doi: 10.1093.
    >> Share

    July 2021
  23. SEMMES EC, Li SH, Hurst JH, Yang Z, et al
    Congenital human cytomegalovirus infection is associated with decreased transplacental IgG transfer efficiency due to maternal hypergammaglobulinemia.
    Clin Infect Dis. 2021 Jul 14. pii: 6321289. doi: 10.1093.
    >> Share

  24. WAMALWA D, Njuguna I, Maleche-Obimbo E, Begnel E, et al
    Cytomegalovirus viremia and clinical outcomes in Kenyan children diagnosed with HIV in hospital.
    Clin Infect Dis. 2021 Jul 2. pii: 6313248. doi: 10.1093.
    >> Share

    June 2021
  25. PAEZ-VEGA A, Gutierrez-Gutierrez B, Aguera ML, Facundo C, et al
    Immunoguided Discontinuation of Prophylaxis for Cytomegalovirus Disease in Kidney Transplant Recipients Treated with Antithymocyte Globulin: A Randomized Clinical Trial.
    Clin Infect Dis. 2021 Jun 22. pii: 6316194. doi: 10.1093.
    >> Share

    April 2021
  26. SASSINE J, Khawaja F, Shigle TL, Handy V, et al
    Refractory and Resistant Cytomegalovirus after Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis Era.
    Clin Infect Dis. 2021 Apr 8. pii: 6217453. doi: 10.1093.
    >> Share

    March 2021
  27. WALL N, Godlee A, Geh D, Jones C, et al
    Latent cytomegalovirus infection and previous capsular polysaccharide vaccination predict poor vaccine responses in older adults, independent of chronic kidney disease.
    Clin Infect Dis. 2021 Mar 17. pii: 6174428. doi: 10.1093.
    >> Share

    February 2021
  28. DORFMAN JR, Balla SR, Pathirana J, Groome MJ, et al
    In utero human cytomegalovirus infection is associated with increased levels of putatively protective maternal antibodies in nonprimary infection: evidence for boosting but not protection.
    Clin Infect Dis. 2021 Feb 9. pii: 6131727. doi: 10.1093.
    >> Share

    January 2021
  29. PEPPA D, Reeves M
    Poor responses to Pneumococcal vaccination in CKD patients - do we need to talk about cytomegalovirus again?
    Clin Infect Dis. 2021 Jan 30. pii: 6124513. doi: 10.1093.
    >> Share

    December 2020
  30. LANZIERI TM, Kruszon-Moran D, Link-Gelles R, Wong P, et al
    Breastfeeding duration and cytomegalovirus seroprevalence among U.S. children aged 1-5 years: The National Health and Nutrition Examination Surveys, 2011-2012 and 2017-2018.
    Clin Infect Dis. 2020 Dec 30. pii: 6055165. doi: 10.1093/cid/ciaa1900.
    >> Share

  31. AKAHOSHI Y, Kimura SI, Inamoto Y, Seo S, et al
    Effect of cytomegalovirus reactivation with or without acute graft-versus-host disease on the risk of nonrelapse mortality.
    Clin Infect Dis. 2020 Dec 20. pii: 6042338. doi: 10.1093/cid/ciaa1871.
    >> Share

  32. PERRY WA, Paulus JK, Price LL, Snydman DR, et al
    Association between lymphopenia at one month post-transplant and infectious outcomes or death in heart transplant recipients.
    Clin Infect Dis. 2020 Dec 6. pii: 6024974. doi: 10.1093/cid/ciaa1800.
    >> Share

    November 2020
  33. HAMEIRI BOWEN D, Sovershaeva E, Charlton B, Schive C, et al
    Cytomegalovirus-Specific Immunoglobulin G is associated with chronic lung disease in children and adolescents from sub-Saharan Africa with perinatal HIV infection.
    Clin Infect Dis. 2020 Nov 26. pii: 6006874. doi: 10.1093/cid/ciaa1757.
    >> Share

  34. IMLAY HN, Kaul DR
    Letermovir and Maribavir for the Treatment and Prevention of Cytomegalovirus Infection in Solid Organ and Stem Cell Transplant Recipients.
    Clin Infect Dis. 2020 Nov 17. pii: 5983750. doi: 10.1093/cid/ciaa1713.
    >> Share

    March 2020
  35. AREND SM, Jedema I
    To Bridge, Blossom, or Boost: That Is the Question.
    Clin Infect Dis. 2020;70:1438-1441.
    >> Share

  36. ZHAO XY, Pei XY, Chang YJ, Yu XX, et al
    First-line Therapy With Donor-derived Human Cytomegalovirus (HCMV)-specific T Cells Reduces Persistent HCMV Infection by Promoting Antiviral Immunity After Allogenic Stem Cell Transplantation.
    Clin Infect Dis. 2020;70:1429-1437.
    >> Share

    February 2020
  37. ROWLAND-JONES S, Yindom LM, Ferrand R
    Reply to Cevik et al.
    Clin Infect Dis. 2020;70:990-991.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016